期刊文献+

GDM患者血糖与母体并发症及新生儿代谢性疾病不良妊娠结局相关性分析 被引量:2

Correlation of blood glucose with adverse pregnancy outcomes of mothers with gestational diabetes mellitus and their newborns
下载PDF
导出
摘要 目的探讨妊娠期糖尿病(GDM)患者血糖水平变化与母体及新生儿不良妊娠结局的关系。方法选取2017年1月至2019年1月在德州市人民医院治疗的GDM患者210例,给予血糖控制,在分娩前1周行持续性动态血糖监测,观察母体及新生儿不良妊娠结局发生情况。结果共有31例孕妇发生不良妊娠结局,发生率为14.76%(31/210);共有98例新生儿发生不良妊娠结局,发生率为46.67%(98/210);发生母体不良妊娠结局者分娩前1周平均血糖水平(MBG)、血糖水平标准差(SDBG)、平均血糖波动幅度(MAGE)、日间血糖平均绝对差(MODD)分别为(6.03±0.91)mmol/L、(1.43±0.32)mmol/L、(2.88±0.43)mmol/L、(1.48±0.32)mmol/L,均明显高于未发生不良妊娠结局者,差异均有统计学意义(均P<0.05);发生新生儿不良妊娠结局孕妇分娩前1周MBG、SDBG、MAGE、MODD分别为(5.98±0.97)mmol/L、(1.40±0.30)mmol/L、(2.80±0.49)mmol/L、(1.43±0.32)mmol/L,均明显高于未发生新生儿不良妊娠结局孕妇,差异均有统计学意义(均P<0.05);logistic回归分析结果显示,MBG、MAGE是GDM患者发生母体不良妊娠结局的影响因素(OR=1.365、1.347,均P<0.05);MBG、MAGE、MODD是GDM患者发生新生儿不良妊娠结局的影响因素(OR=1.380、1.369、1.347,均P<0.05)。结论GDM患者血糖波动情况对母体及新生儿不良妊娠结局有所影响,在临床上应给予重视。 Objective To explore the correlation of blood glucose with adverse pregnancy outcomes of mothers with gestational diabetes mellitus(GDM)and their newborns.Methods 210 patients with GDM who were treated in Dezhou People’s Hospital from January,2017 to January,2019 were selected for blood glucose control.Continuous dynamic blood glucose monitoring was conducted on them one week before delivery.The adverse pregnancy outcomes of the mothers and their newborns were observed.Results 31 pregnant women had adverse pregnancy outcomes,with an incidence of 14.76%(31/210).98 newborns had adverse outcomes,with an incidence of 46.67%(98/210).The mean blood glucose level(MBG),standard deviation of blood glucose level(SDBG),mean amplitude of glycemicexcursions(MAGE),and mean of daily differences(MODD)in the first week before delivery in the women with adverse pregnancy outcomes were(6.03±0.91)mmol/L,(1.43±0.32)mmol/L,(2.88±0.43)mmol/L,and(1.48±0.32)mmol/L,which were significantly higher than those in the women without adverse pregnancy outcomes(all P<0.05).The MBG,SDBG,MAGE and MODD in the first week before delivery of the pregnant women with newborn adverse outcome were(5.98±0.97)mmol/L,(1.40±0.30)mmol/L,(2.80±0.49)mmol/L,and(1.43±0.32)mmol/L,which were significantly higher than those of the pregnant women without newborn adverse outcomes(all P<0.05).The results of logistic regression analysis showed that MBG and MAGE were the influencing factors of maternal adverse pregnancy outcomes in the GDM patients(OR=1.365 and 1.347;both P<0.05);and MBG,MAGE,and MODD were the influencing factors of newborn adverse pregnancy outcomes in the GDM patients(OR=1.380,1.369,and 1.347;all P<0.05).Conclusion The fluctuation of blood glucose in GDM patients has some influence on the adverse pregnancy outcomes of the mothers and their newborns,which should be paid more attention in clinical practice.
作者 王德亮 巩瑞春 Wang Deliang;Gong Ruichun(Department of Obstetrics,Dezhou People’s Hospital,Dezhou 253000,China;Department of Obstetrics,Dezhou Maternal and Child Health Care Hospital,Dezhou 253000,China)
出处 《国际医药卫生导报》 2020年第10期1381-1384,共4页 International Medicine and Health Guidance News
关键词 妊娠期糖尿病 血糖 母体 新生儿 不良妊娠结局 Gestational diabetes mellitus Blood glucose Maternal Newborns Adverse pregnancy outcomes
  • 相关文献

参考文献7

二级参考文献54

  • 1魏华莉,刘亚静.妊娠期糖尿病妊娠结局及对新生儿影响的临床分析[J].中华临床医师杂志(电子版),2011,5(18):5479-5480. 被引量:37
  • 2HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcomes[J].N Engl J Med, 2008, 358(19): 1991-2002.
  • 3Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy [J].Diabetes Care, 2005, 28 (5) : 1231-1239.
  • 4McLachlan K, Jenkins A, OrNeal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy[J].Aust NZJ Obstet Gynaecol, 2007, 47(3) : 186- 190.
  • 5Kestil~i KK, Ekblad UU, R6nnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus[J]. Diabetes Res Clin Pract, 2007, 77(2): 174-179.
  • 6Su JB, Wang XQ, Chen JF, et al. Glycemic variability in gestational diabetes mellitus and its association with /3 cell function[J]. Endocrine, 2013, 43(2): 370-375.
  • 7American Diabetes Association. Standards of medical care in diabetes-2011[J]. Diabetes Care, 2011, 34 (Suppl 1) . $11- $61.
  • 8Service FJ, OrBrien PC, Rizza RA. Measurements of glucose control[J]. Diabetes Care 1987, 10(10): 225-237.
  • 9Service FJ, Nelson RL. Characteristics of glycemic stability [J]. Diabetes Care, 1980, 3(1): 58-62.
  • 10Dalfrd MG, Sartore G, Di Cianni G, et al. Glucose variability in diabetic pregnaney[J]. Diabetes Technol Ther, 2011, 13 (8) : 853-859.

共引文献227

同被引文献9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部